Jeffrey Tice, MD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jeffrey Tice, MD

Associate Professor, Department of Medicine (General Internal Medicine), UCSF

Jeff.Tice@ucsf.edu

Phone: (844) 727-8273 (appts)
Box 0320, UCSF
San Francisco, CA 94143-0320

UCSF Profiles | Physician Referral Directory

Cancer Center Membership

Member » Breast Oncology

Education

Dartmouth College, Hanover, NH, BA, 06/1983, Math; Philosophy
San Francisco State University, 05/1989, Pre-medical classed
University of California, San Francisco, MD, 06/1994, Medicine
University of California, San Francisco, 06/1997, Internal Medicine
University of California, San Francisco, Postdoctoral, 06/1999, Research/Epidmiology


Professional Experience

  • 1984-1986
    Peace Corps Volunteer, Bangassou, Central African Republic
  • 1987 - 1992
    Programmer/Analyst III, Department of Epidemiology, University of California, San Francisco
  • 1999-2004
    Assistant Adjunct Professor of Medicine, Division of General Internal Medicine, Department of Medicine, University of California, San Francisco
  • 2005-2011
    Assistant Professor of Medicine, Division of General Internal Medicine, Department of Medicine, University of California, San Francisco
  • 2012-present
    Associate Professor of Medicine, Division of General Internal Medicine, Department of Medicine, University of California, San Francisco

Honors & Awards

  • 2013
    UCSF Research Mentoring Award
  • 2009
    Society of General Internal Medicine- CA Region- Outstanding Clinician Investigator Award
  • 2003
    Robert Crede Award for Clinical Research, UCSF Division of General Internal Medicine
  • 2002-2004
    Building Interdisciplinary Research Careers in Women's Health (BIRCWH) Faculty Scholar
  • 1994
    Alpha Omega Alpha, UCSF
  • 1990-1994
    Regents Scholarship, UCSF
  • 1983
    Summa Cum Laude, Dartmouth College
  • 1982
    Phi Beta Kappa, Dartmouth College
  • 1979-1983
    Rufous Choate Scholar, Dartmouth College
  • 1979-1983
    IBM Thomas J. Watson Scholar

Selected Publications

  1. Shieh Y, Eklund M, Madlensky L, Sawyer SD, Thompson CK, Stover Fiscalini A, Ziv E, Van't Veer LJ, Esserman LJ, Tice JA. Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial. J Natl Cancer Inst. 2017 Jan; 109(5).
    View on PubMed
  2. Kerlikowske K, Gard CC, Tice JA, Ziv E, Cummings SR, Miglioretti DL. Risk Factors That Increase Risk of Estrogen Receptor-Positive and -Negative Breast Cancer. J Natl Cancer Inst. 2017 May; 109(5).
    View on PubMed
  3. Whittington MD, McQueen RB, Ollendorf DA, Tice JA, Chapman RH, Pearson SD, Campbell JD. Assessing the value of mepolizumab for severe eosinophilic asthma: a cost-effectiveness analysis. Ann Allergy Asthma Immunol. 2016 Dec 03.
    View on PubMed
  4. Shieh Y, Hu D, Ma L, Huntsman S, Gard CC, Leung JW, Tice JA, Vachon CM, Cummings SR, Kerlikowske K, Ziv E. Breast cancer risk prediction using a clinical risk model and polygenic risk score. Breast Cancer Res Treat. 2016 Aug 26.
    View on PubMed
  5. Kazi DS, Moran AE, Coxson PG, Penko J, Ollendorf DA, Pearson SD, Tice JA, Guzman D, Bibbins-Domingo K. Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease. JAMA. 2016 Aug 16; 316(7):743-753.
    View on PubMed
  6. Reed SJ, Shore KK, Tice JA. Effectiveness and Value of Integrating Behavioral Health Into Primary Care. JAMA Intern Med. 2016 May 1; 176(5):691-2.
    View on PubMed
  7. Dallal CM, Lacey JV, Pfeiffer RM, Bauer DC, Falk RT, Buist DS, Cauley JA, Hue TF, LaCroix AZ, Tice JA, Veenstra TD, Xu X, Brinton LA. Estrogen Metabolism and Risk of Postmenopausal Endometrial and Ovarian Cancer: the B~FIT Cohort. Horm Cancer. 2016 Feb; 7(1):49-64.
    View on PubMed
  8. Tice JA, Kazi DS, Pearson SD. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors for Treatment of High Cholesterol Levels: Effectiveness and Value. JAMA Intern Med. 2016 Jan 1; 176(1):107-8.
    View on PubMed
  9. Chahal HS, Marseille EA, Tice JA, Pearson SD, Ollendorf DA, Fox RK, Kahn JG. Cost-effectiveness of Early Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis in a US Treatment-Naive Population. JAMA Intern Med. 2016 Jan 1; 176(1):65-73.
    View on PubMed
  10. Livaudais-Toman J, Karliner LS, Tice JA, Kerlikowske K, Gregorich S, Pérez-Stable EJ, Pasick RJ, Chen A, Quinn J, Kaplan CP. Impact of a primary care based intervention on breast cancer knowledge, risk perception and concern: A randomized, controlled trial. Breast. 2015 Dec; 24(6):758-66.
    View on PubMed
  11. Tice JA, Chahal HS, Ollendorf DA. Comparative Clinical Effectiveness and Value of Novel Interferon-Free Combination Therapy for Hepatitis C Genotype 1: Summary of California Technology Assessment Forum Report. JAMA Intern Med. 2015 Sep; 175(9):1559-60.
    View on PubMed
  12. Hart V, Reeves KW, Sturgeon SR, Reich NG, Sievert LL, Kerlikowske K, Ma L, Shepherd J, Tice JA, Mahmoudzadeh AP, Malkov S, Sprague BL. The Effect of Change in Body Mass Index on Volumetric Measures of Mammographic Density. Cancer Epidemiol Biomarkers Prev. 2015 Nov; 24(11):1724-30.
    View on PubMed
  13. Tice JA, Miglioretti DL, Li CS, Vachon CM, Gard CC, Kerlikowske K. Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer. J Clin Oncol. 2015 Oct 1; 33(28):3137-43.
    View on PubMed
  14. Falk RT, Dallal CM, Lacey JV, Bauer DC, Buist DS, Cauley JA, Hue TF, LaCroix AZ, Tice JA, Pfeiffer RM, Xu X, Veenstra TD, Brinton LA. Estrogen Metabolites Are Not Associated with Colorectal Cancer Risk in Postmenopausal Women. Cancer Epidemiol Biomarkers Prev. 2015 Sep; 24(9):1419-22.
    View on PubMed
  15. Kerlikowske K, Zhu W, Tosteson AN, Sprague BL, Tice JA, Lehman CD, Miglioretti DL. Identifying women with dense breasts at high risk for interval cancer: a cohort study. Ann Intern Med. 2015 May 19; 162(10):673-81.
    View on PubMed
  16. Kerlikowske K, Gard CC, Sprague BL, Tice JA, Miglioretti DL. One versus Two Breast Density Measures to Predict 5- and 10-Year Breast Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2015 Jun; 24(6):889-97.
    View on PubMed
  17. Vachon CM, Pankratz VS, Scott CG, Haeberle L, Ziv E, Jensen MR, Brandt KR, Whaley DH, Olson JE, Heusinger K, Hack CC, Jud SM, Beckmann MW, Schulz-Wendtland R, Tice JA, Norman AD, Cunningham JM, Purrington KS, Easton DF, Sellers TA, Kerlikowske K, Fasching PA, Couch FJ. The contributions of breast density and common genetic variation to breast cancer risk. J Natl Cancer Inst. 2015 May; 107(5).
    View on PubMed
  18. Ollendorf DA, Tice JA, Pearson SD. The comparative clinical effectiveness and value of simeprevir and sofosbuvir for chronic hepatitis C virus infection. JAMA Intern Med. 2014 Jul; 174(7):1170-1.
    View on PubMed
  19. Bolton KC, Mace JL, Vacek PM, Herschorn SD, James TA, Tice JA, Kerlikowske K, Geller BM, Weaver DL, Sprague BL. Changes in breast cancer risk distribution among Vermont women using screening mammography. J Natl Cancer Inst. 2014 Aug; 106(8).
    View on PubMed
  20. Kaplan CP, Livaudais-Toman J, Tice JA, Kerlikowske K, Gregorich SE, Pérez-Stable EJ, Pasick RJ, Chen A, Quinn J, Karliner LS. A randomized, controlled trial to increase discussion of breast cancer in primary care. Cancer Epidemiol Biomarkers Prev. 2014 Jul; 23(7):1245-53.
    View on PubMed

Go to UCSF Profiles, powered by CTSI